2025-05-02 22:10:21
Latest Post
Colab Platforms Ltd fixes May 21, 2025 as record date for 2 For 1 stock split
RateGain Launches Industry''s First AI-Powered ARI Management Engine
TCS Collaborates with SAP to Enable Enterprise-wide GenAI and Cloud Adoption For its Customers
Zydus receives final approval from USFDA for Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg
Coforge Divests AdvantageGo to Sapiens
Stock Report
Astec LifeSciences Ltd's consolidated PAT rises to Rs. 17.84 crore in Q2FY21
Posted On : 2020-10-29 17:14:26( TIMEZONE : IST )
ASTEC LIFESCIENCES LIMITED has reported financial results for the period ended September 30, 2020.
Financial Results (Q2 FY20-21) - QoQ Comparison
The company has reported total income of Rs.156.84 crores during the period ended September 30, 2020 as compared to Rs.113.19 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.17.84 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.16.18 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.9.11 for the period ended September 30, 2020 as compared to Rs.8.26 for the period ended June 30, 2020.
| Financials | Q2 FY20-21 | Q1 FY20-21 | % Change |
| Total Income | ₹ 156.84 crs | ₹ 113.19 crs |  38.56% |
| Net Profit | ₹ 17.84 crs | ₹ 16.18 crs | 10.26% |
| EPS | ₹ 9.11 | ₹ 8.26 | 10.29% |
Financial Results (Q2 FY20-21) - YoY Comparison
The company has reported total income of Rs.156.84 crores during the period ended September 30, 2020 as compared to Rs.142.03 crores during the period ended September 30, 2019.
The company has posted net profit / (loss) of Rs.17.84 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.5.28 crores for the period ended September 30, 2019.
The company has reported EPS of Rs.9.11 for the period ended September 30, 2020 as compared to Rs.2.70 for the period ended September 30, 2019.
| Financials | Q2 FY20-21 | Q2 FY19-20 | % Change |
| Total Income | ₹ 156.84 crs | ₹ 142.03 crs | 10.43% |
| Net Profit | ₹ 17.84 crs | ₹ 5.28 crs | 237.88% |
| EPS | ₹ 9.11 | ₹ 2.70 | 237.41% |
Financial Results (6 months ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.270.04 crores during the 6 months period ended September 30, 2020 as compared to Rs.219.96 crores during the 6 months period ended September 30, 2019.
The company has posted net profit / (loss) of Rs.34.03 crores for the 6 months period ended September 30, 2020 as against net profit / (loss) of Rs.4.17 crores for the 6 months period ended September 30, 2019.
The company has reported EPS of Rs.17.37 for the 6 months period ended September 30, 2020 as compared to Rs.2.13 for the 6 months period ended September 30, 2019.
| Financials | Half-Year Ended FY20-21 | Half-Year Ended FY19-20 | % Change |
| Total Income | ₹ 270.04 crs | ₹ 219.96 crs | 22.77% |
| Net Profit | ₹ 34.03 crs | ₹ 4.17 crs | 716.07% |
| EPS | ₹ 17.37 | ₹2.13 | 715.49% |
Shares of ASTEC LIFESCIENCES LIMITED was last trading in BSE at Rs.1090 as compared to the previous close of Rs. 1111.75. The total number of shares traded during the day was 4643 in over 917 trades.
The stock hit an intraday high of Rs. 1112.8 and intraday low of 1078.3. The net turnover during the day was Rs. 5101683.
